1. HOME
  2. Graduate School
  3. The Ph.D. Program of Pharmaceutical Sciences

The Ph.D. Program of Pharmaceutical Sciences

Developing Professionals Equipped with Excellent Research Capabilities and Skills

The Ph.D. Program of Pharmaceutical Sciences pursues interdisciplinary education and research for leading-edge drug development, and provides education on natural medicines and clinical pharmacy. The objective of the program is to develop researchers and technologists who can play active roles in pharmacy-related fields, such as drug development science, by applying the knowledge and skills they have acquired.

List of Subjects and Credits

Subject Name Credits Required/
Elective
Lecture Seminar Experiment/
Special Research
Molecular Biopharmaceutical Sciences 2 Elective
Molecular Medicinal Science 2 Elective
Advanced Lecture in Advanced Oriental and Western Medicine 2 Elective
Practice in Pharmaceutical Formulation Development 1 Elective
Practice in Pharmacokinetics 1 Elective
International Pharmaceutical Sciences 2 Elective
Internships 4 Elective
Seminar for Pharmaceutical Sciences 4 Required
Special Research for Pharmaceutical Sciences 14 Required
Research Ethics and Methods (e-Learning) 1 Optional
Japanese Language and Culture (for foreign students) 4 Optional
Total 13 4 20
Required Number of Credits
Required subjects 18
Elective subject 2
Total 20 credits or more

Department of Pharmaceutical Sciences

※Scroll left and right to see full diagram

Message from Almnus

Hisao Shimizu

Bachelor’s Degree Holder for 2003, Master’s Degree Holder for 2005 and Ph.D. Holder for 2008

I work as a researcher at a pharmaceutical company that engages in research and development for new drugs on a global basis, under a shared goal of delivering innovative new drugs for patients. New drug development is an extremely challenging mission that consumes a significant amount of time and effort, involving target searches, chemosynthesis, drug efficacy evaluations, toxicity evaluations, pharmacokinetic evaluations, formulation, and clinical trials.
I am involved in research involving pharmacokinetic evaluation, so I currently mainly analyze medicine blood concentration. At the research institute, we frequently discover new candidate compounds, which range widely from low molecular compounds to high molecular compounds such as nuclear acids and peptides. We are also required to analyze not only drugs, but also metabolites and biomarkers, in a highly sensitive manner. Developing analysis methods that closely reflect these compounds’ characteristics is rewarding to me, as I help develop new drugs. I studied at the University of Toyama during my undergraduate and graduate school years; as an adult professional, I now feel acutely that the specialized knowledge and experience I obtained at the University served as an important foundation for my work as a scientist.

Course for Developing Highly Skilled Professionals

The Graduate School of Medicine and Pharmaceutical Sciences (Ph.D. course) runs the Program for Developing Highly Skilled Professionals Based on Natural Medicine and Pharmaceutical Sciences (PDNP) for prospective students. The objective of this course is to develop human resources to play key roles in drug therapy as work-ready individuals in team-based medicine at hospitals, as well as highly skilled professionals who engage in pharmaceutical science research, quality control, and development at pharmaceutical companies, by hosting students in Japan and foreign countries for the doctorate program.The school also seeks to help further develop the field of pharmaceutical sciences by tapping into the Toyama area’s historical traditions, as well as the University’s collective research and education, and through developing specialized professionals. The Pharmaceutical Sciences major allows students to take curriculum courses to develop themselves into specialized experts associated with natural medicines, alongside comprehensive experience of research and development and quality control through extended internships at pharmaceutical companies well-versed in such medicines.